• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

植入式自动心脏复律除颤器植入后电击的精算发病率及发生模式。

Actuarial incidence and pattern of occurrence of shocks following implantation of the automatic implantable cardioverter defibrillator.

作者信息

Fogoros R N, Elson J J, Bonnet C A

机构信息

Division of Cardiology, Medical College of Pennsylvania, Allegheny General Hospital, Pittsburgh 15212.

出版信息

Pacing Clin Electrophysiol. 1989 Sep;12(9):1465-73. doi: 10.1111/j.1540-8159.1989.tb06151.x.

DOI:10.1111/j.1540-8159.1989.tb06151.x
PMID:2476775
Abstract

The actuarial incidence and pattern of occurrence of shocks were analyzed in 65 patients after implantation of the automatic implantable cardioverter defibrillator. During a mean follow-up of 25 +/- 21 months only one patient died suddenly, and this patient had a nonfunctioning device at the time of death. The long-term actuarial risk of death from any cause in the patients who received appropriate shocks was not significantly different than for the entire group. The 1- and 4-year cumulative risk of receiving any shock was 51 +/- 7% and 81 +/- 11%; of receiving an appropriate shock was 33 +/- 7% and 64 +/- 10%; of receiving a spurious shock was 17 +/- 5% and 21 +/- 6%; and of receiving an "indeterminate" shock was 19 +/- 6% and 52 +/- 10%. In 14 patients who were followed for 24 months without receiving an appropriate shock, the actuarial risk of receiving an appropriate shock was 29 +/- 14% during the next 24 months. The mean number of shocks delivered during appropriate episodes was 1.6 +/- 0.9, which was significantly lower than the mean of 4.0 +/- 2.0 shocks during spurious episodes (P less than 0.02). The mean number of shocks during indeterminate episodes was 1.7 +/- 1.5. Our data confirms the efficacy of the implantable defibrillator in preventing sudden death. The majority of patients with this device receive appropriate shocks during long-term follow-up, and the cumulative incidence of appropriate shocks increases steadily for at least 4 years. In contrast, the cumulative incidence of spurious shocks plateaus at about 12 months. Our data suggests that many "indeterminate" shocks actually appear to be appropriate.

摘要

对65例植入自动植入式心脏复律除颤器的患者的电击发生率及发生模式进行了分析。在平均25±21个月的随访期内,仅1例患者突然死亡,该患者死亡时装置无功能。接受适当电击的患者中任何原因导致的长期死亡精算风险与整个组相比无显著差异。接受任何电击的1年和4年累积风险分别为51±7%和81±11%;接受适当电击的风险分别为33±7%和64±10%;接受误放电击的风险分别为17±5%和21±6%;接受“不确定”电击的风险分别为19±6%和52±10%。在14例随访24个月未接受适当电击的患者中,未来24个月接受适当电击的精算风险为29±14%。适当电击发作期间的平均电击次数为1.6±0.9次,显著低于误放电击发作期间的平均4.0±2.0次(P<0.02)。不确定电击发作期间的平均电击次数为1.7±1.5次。我们的数据证实了植入式除颤器在预防猝死方面的有效性。该装置的大多数患者在长期随访期间接受了适当的电击,并且适当电击的累积发生率至少4年稳步上升。相比之下,误放电击的累积发生率在约12个月时趋于平稳。我们的数据表明,许多“不确定”电击实际上似乎是适当的。

相似文献

1
Actuarial incidence and pattern of occurrence of shocks following implantation of the automatic implantable cardioverter defibrillator.植入式自动心脏复律除颤器植入后电击的精算发病率及发生模式。
Pacing Clin Electrophysiol. 1989 Sep;12(9):1465-73. doi: 10.1111/j.1540-8159.1989.tb06151.x.
2
When is it safe not to replace an implantable cardioverter defibrillator generator?何时不更换植入式心脏复律除颤器发生器是安全的?
Pacing Clin Electrophysiol. 1991 Nov;14(11 Pt 2):1875-80. doi: 10.1111/j.1540-8159.1991.tb02783.x.
3
Does reception of appropriate shocks from the implantable cardioverter defibrillator affect survival?接受植入式心脏复律除颤器的适当电击会影响生存率吗?
Pacing Clin Electrophysiol. 1991 Nov;14(11 Pt 2):1929-34. doi: 10.1111/j.1540-8159.1991.tb02792.x.
4
Shock occurrence and survival in 241 patients with implantable cardioverter-defibrillator therapy.241例接受植入式心脏复律除颤器治疗患者的休克发生情况及生存情况
Circulation. 1993 Jun;87(6):1880-8. doi: 10.1161/01.cir.87.6.1880.
5
Long-term outcome with the automatic implantable cardioverter-defibrillator.
J Am Coll Cardiol. 1989 May;13(6):1353-61. doi: 10.1016/0735-1097(89)90310-0.
6
Ventricular fibrillation in patients without significant structural heart disease: a multicenter experience with implantable cardioverter-defibrillator therapy.无明显结构性心脏病患者的心室颤动:植入式心脏复律除颤器治疗的多中心经验
J Am Coll Cardiol. 1993 May;21(6):1406-12. doi: 10.1016/0735-1097(93)90317-t.
7
Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.新型植入式起搏除颤器所提供的自动多模式设备治疗室性快速心律失常的疗效。一项欧洲多中心研究(涉及102例植入)的结果
Circulation. 1992 Aug;86(2):363-74. doi: 10.1161/01.cir.86.2.363.
8
Survival of patients with the automatic implantable cardioverter defibrillator.植入式自动心脏复律除颤器患者的生存率。
Pacing Clin Electrophysiol. 1988 Nov;11(11 Pt 2):2059-63. doi: 10.1111/j.1540-8159.1988.tb06350.x.
9
Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system.使用带有三电极系统的植入式心脏复律除颤器进行心内膜除颤的初步临床经验。
Arch Intern Med. 1989 Oct;149(10):2333-9.
10
Occurrence of ICD shocks and patient survival.植入式心律转复除颤器(ICD)电击的发生情况及患者生存率。
Pacing Clin Electrophysiol. 1991 Feb;14(2 Pt 2):273-9. doi: 10.1111/j.1540-8159.1991.tb05106.x.

引用本文的文献

1
Sudden cardiac death unresponsive to implantable defibrillator therapy: an urgent target for clinicians, industry and government.对植入式除颤器治疗无反应的心脏性猝死:临床医生、行业和政府的紧迫目标。
J Interv Card Electrophysiol. 2005 Nov;14(2):71-8. doi: 10.1007/s10840-005-4547-9.
2
R-wave detection by subcutaneous ECG. Possible use for analyzing R-R variability.通过皮下心电图检测R波。在分析R-R间期变异性方面的可能应用。
Ann Noninvasive Electrocardiol. 2001 Jan;6(1):18-23. doi: 10.1111/j.1542-474x.2001.tb00081.x.
3
Is primary antiarrhythmic drug therapy for ventricular arrhythmias obsolete?
用于室性心律失常的一线抗心律失常药物治疗过时了吗?
Curr Cardiol Rep. 1999 Nov;1(4):268-73. doi: 10.1007/s11886-999-0049-1.
4
Implantable cardioverter-defibrillator therapy: influence of left ventricular function on long-term results.植入式心脏复律除颤器治疗:左心室功能对长期疗效的影响。
J Interv Card Electrophysiol. 1997 Nov;1(3):211-20. doi: 10.1023/a:1009716822824.
5
Modification of the circadian pattern of ventricular tachyarrhythmias by beta-blocker therapy.β受体阻滞剂治疗对室性快速性心律失常昼夜节律模式的影响。
Clin Cardiol. 1997 Mar;20(3):253-7. doi: 10.1002/clc.4960200313.
6
Efficacy of a tiered therapy defibrillator system used to treat recurrent ventricular arrhythmias refractory to drugs.用于治疗对药物难治的复发性室性心律失常的分层治疗除颤器系统的疗效。
Br Heart J. 1993 Jul;70(1):61-9. doi: 10.1136/hrt.70.1.61.